A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes. . . . → Read More: Start-Up Targets Extra DNA in Cancer, Raises $46.4M
|
|||||
|
|
A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells. . . . → Read More: Gel, Crispr Help Defeat Cancer Drug Obstacles 
A grant from National Institutes of Health is funding a system using augmented reality and holography to improve minimally-invasive repair of blood vessels. . . . → Read More: NIH Funds Augmented-Reality Endovascular System 
Results of a small-scale clinical trial show an experimental treatment using an injectable gel to repair damage from a heart attack is safe for patients. . . . → Read More: Hydrogel Shown Safe to Repair Heart Damage 
A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles. . . . → Read More: Gene-Editing Biotech Gains $34M in Early Funds 
A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics. . . . → Read More: Spin-Off Licensing Athletic Microbiome Technology  Comments are closed  Intellectual property, New products  biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, university 
A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria. . . . → Read More: Carb-X Funds Drug-Resistant Bacterial Vaccine Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, Europe, grant, licensing, life sciences, pharmaceuticals, preclinical 
A new enterprise has launched to develop live microbial treatments for urinary tract infections and other diseases originating in vaginal bacterial communities. . . . → Read More: Company Forms to Treat Vaginal Microbial Disorders Comments are closed Intellectual property, New products biomedical, biotechnology, clinical trials, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, preclinical, university 
A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially catastrophic events in real time by analyzing text and images on social media. . . . → Read More: A.I. Helps Visualize Emergency Social Media Data Comments are closed Intellectual property, New products computer science, engineering, entrepreneurs, licensing, mathematics, physical sciences, software, university 
A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal Comments are closed Intellectual property Asia, biomedical, biotechnology, clinical trials, Japan, licensing, life sciences, pharmaceuticals, university |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||